Bruker Corp
BRKR45.130USD
-1.240-2.67%
Close 12/12, 16:00（ET）Quotes delayed by 15 min
6.83BMarket Cap
LossP/E TTM
More Details of Bruker Corp Company
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Bruker Corp Info
Ticker SymbolBRKR
Company nameBruker Corp
IPO dateAug 04, 2000
CEOPrause (Burkhard A)
Number of employees11396
Security typeOrdinary Share
Fiscal year-endAug 04
Address40 Manning Rd
CityBILLERICA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01821-3915
Phone19786633660
Websitehttps://www.bruker.com/
Ticker SymbolBRKR
IPO dateAug 04, 2000
CEOPrause (Burkhard A)
Company Executives of Bruker Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+6.15%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+13.38%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-3.83%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
21.33K
-4.14%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
14.72K
+5.48%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
10.03K
-8.41%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+6.15%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+13.38%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product
634.70M
79.60%
Product And Service Other
162.70M
20.40%
Service and other revenue
162.70M
20.40%
By RegionUSD
Name
Revenue
Proportion
United States
222.90M
27.95%
Rest of Europe
213.40M
26.76%
Rest of Asia Pacific
127.40M
15.98%
China
114.70M
14.38%
Other
59.90M
7.51%
Germany
59.10M
7.41%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product
634.70M
79.60%
Product And Service Other
162.70M
20.40%
Service and other revenue
162.70M
20.40%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.83%
Pallas Capital Advisors LLC
6.24%
Other
43.50%
Shareholders
Shareholders
Proportion
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.83%
Pallas Capital Advisors LLC
6.24%
Other
43.50%
Shareholder Types
Shareholders
Proportion
Investment Advisor
50.95%
Individual Investor
31.97%
Investment Advisor/Hedge Fund
25.95%
Hedge Fund
8.24%
Research Firm
2.61%
Pension Fund
1.17%
Sovereign Wealth Fund
0.76%
Bank and Trust
0.38%
Insurance Company
0.21%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
887
137.27M
94.12%
+111.45K
2025Q3
908
137.16M
94.45%
+8.73M
2025Q2
904
127.18M
89.58%
+1.13M
2025Q1
886
125.13M
85.85%
-5.11M
2024Q4
855
125.47M
82.99%
+4.02M
2024Q3
812
120.93M
80.76%
+2.25M
2024Q2
782
118.65M
76.64%
+5.15M
2024Q1
766
113.09M
82.81%
-916.64K
2023Q4
748
112.27M
83.16%
-472.55K
2023Q3
723
112.40M
83.64%
-8.12M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Laukien (Frank H)
40.41M
26.64%
+31.93K
+0.08%
Aug 15, 2025
Orbis Investment Management Ltd.
4.68M
3.08%
+4.68M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
7.47M
4.92%
-2.35M
-23.89%
Jun 30, 2025
The Vanguard Group, Inc.
10.40M
6.86%
-122.86K
-1.17%
Jun 30, 2025
Pallas Capital Advisors LLC
9.50M
6.26%
+5.56K
+0.06%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.40M
6.2%
-803.98K
-7.88%
Jun 30, 2025
Laukien (Joerg C)
7.52M
4.95%
--
--
Apr 01, 2025
T. Rowe Price Investment Management, Inc.
11.43M
7.53%
-952.71K
-7.69%
Jun 30, 2025
State Street Investment Management (US)
3.78M
2.49%
-42.78K
-1.12%
Jun 30, 2025
Edmond de Rothschild Asset Management (France) S.A.
1.51M
0.99%
+1.51M
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust NYSE Arca Biotechnology Index Fund
3.71%
ProShares Nanotechnology ETF
3.34%
State Street SPDR S&P Kensho Future Security ETF
1.27%
Ballast Small/Mid Cap ETF
1.13%
AB Disruptors ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
0.57%
iShares Health Innovation Active ETF
0.4%
iShares Biotechnology ETF
0.36%
JPMorgan Active Small Cap Value ETF
0.31%
View more
First Trust NYSE Arca Biotechnology Index Fund
Proportion3.71%
ProShares Nanotechnology ETF
Proportion3.34%
State Street SPDR S&P Kensho Future Security ETF
Proportion1.27%
Ballast Small/Mid Cap ETF
Proportion1.13%
AB Disruptors ETF
Proportion0.63%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
Proportion0.57%
iShares Health Innovation Active ETF
Proportion0.4%
iShares Biotechnology ETF
Proportion0.36%
JPMorgan Active Small Cap Value ETF
Proportion0.31%
Dividend
A total of
138.20M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 04, 2025
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025
Dec 08, 2025
Jan 02, 2026
Dec 08, 2025
Aug 12, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025
Sep 23, 2025
Oct 03, 2025
Sep 23, 2025
May 15, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 27, 2025
Jun 16, 2025
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 14, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Bruker Corp?
The top five shareholders of Bruker Corp are:
Laukien (Frank H) holds 40.41M shares, accounting for 26.64% of the total shares.
Orbis Investment Management Ltd. holds 4.68M shares, accounting for 3.08% of the total shares.
Fidelity Management & Research Company LLC holds 7.47M shares, accounting for 4.92% of the total shares.
The Vanguard Group, Inc. holds 10.40M shares, accounting for 6.86% of the total shares.
Pallas Capital Advisors LLC holds 9.50M shares, accounting for 6.26% of the total shares.
Laukien (Frank H) holds 40.41M shares, accounting for 26.64% of the total shares.
Orbis Investment Management Ltd. holds 4.68M shares, accounting for 3.08% of the total shares.
Fidelity Management & Research Company LLC holds 7.47M shares, accounting for 4.92% of the total shares.
The Vanguard Group, Inc. holds 10.40M shares, accounting for 6.86% of the total shares.
Pallas Capital Advisors LLC holds 9.50M shares, accounting for 6.26% of the total shares.
What are the top three shareholder types of Bruker Corp?
The top three shareholder types of Bruker Corp are:
Laukien (Frank H)
Orbis Investment Management Ltd.
Fidelity Management & Research Company LLC
Laukien (Frank H)
Orbis Investment Management Ltd.
Fidelity Management & Research Company LLC
How many institutions hold shares of Bruker Corp (BRKR)?
As of 2025Q4, 887 institutions hold shares of Bruker Corp, with a combined market value of approximately 137.27M, accounting for 94.12% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.33%.
What is the biggest source of revenue for Bruker Corp?
In FY2025Q2, the Product business generated the highest revenue for Bruker Corp, amounting to 634.70M and accounting for 79.60% of total revenue.
